The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
philogen | 374 |
bayer schering pharma | 31 |
philochem | 3 |
schering corporation | 3 |
philogen s. r. l.;schering | 1 |
shering | 1 |
filodzhen | 1 |
philogen s. p. a.;schering | 1 |
philogen | 41 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
an antigen associated with rheumatoid arthritis | 37 | 2007 |
the ed-a antigen of fibrinogen is associated with the neovas culature of tumor metastases | 31 | 2007 |
the ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases | 29 | 2007 |
antigens associated with inflammatory bowel disease | 22 | 2012 |
combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule bind… 🛈 | 20 | 2008 |
targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b | 19 | 2003 |
antibodies derived from anti ed-b l19 and targeting tumor vasculature | 17 | 2002 |
il22 immunoconjugates | 17 | 2015 |
antibodies against tenascin-c | 15 | 2004 |
immunocytokines for cancer treatment in combination with chemotherapeutic agents | 15 | 2007 |